Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era.
<h4>Background</h4>Pathological and clinical stage are associated with prostate cancer-specific survival after prostatectomy. With PSA screening, the post-surgery prognostic utility of clinical stage is debatable in studies seeking to identify new biomarkers. Few studies have investigate...
Guardado en:
Autores principales: | Maxine M Chen, Jaquelyn L Jahn, John R Barber, Misop Han, Meir J Stampfer, Elizabeth A Platz, Kathryn L Penney |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8daf3c01f615479798bbafbc98d26002 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation
por: Navneeta Bansal, et al.
Publicado: (2017) -
PSA journal
Publicado: (1947) -
Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA
por: Julius Gudmundsson, et al.
Publicado: (2018) -
Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer
por: Samuel Carbunaru, et al.
Publicado: (2021) -
Correlations between integrin ανβ6 expression and clinico-pathological features in stage B and stage C rectal cancer.
por: Seong Beom Ahn, et al.
Publicado: (2014)